Delivery Order SPE2DB22D1106-SPE2DB25FEXD7
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 27mg tablets, valued at $1,173.82. This firm fixed-price, non-competitive delivery order is scheduled for completion by December 12, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework. The order will be fulfilled from the company's operations in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,786.94 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) on May 27, 2025, with completion scheduled for May 28, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) valued at $11,257.85. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $26,934.45 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on September 11, 2025, with completion targeted for September 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $9,033.73. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $22,053.48 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Concerta ER 36 mg tablets (100-count bottles) valued at $6,791.05 with a firm fixed price arrangement. This non-set-aside contract represents a child delivery order executed under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company...
- The Defense Logistics Agency awarded a $1,580.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This contract, with an ultimate completion date of October 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,397.53 for 100 tablets of Concerta ER 36 mg on December 8, 2025, with completion expected by December 9, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $15,296.82 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units). This non-competitive, firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This award represents a child contract under the company's...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEXD7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,786.94 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying an extensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's capability to fulfill this delivery order for methylphenidate extended-release tablets—a medication commonly used in military healthcare settings for attention deficit hyperactivity disorder treatment—demonstrates its role as a primary vendor supporting Defense Health Agency operations and other government healthcare systems through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/10/25 |